ALCON FDA Approval NDA 017063

NDA 017063

ALCON

FDA Drug Application

Application #017063

Application Sponsors

NDA 017063ALCON

Marketing Status

Discontinued001

Application Products

001SOLUTION;ORAL100GM/220ML0ISMOTICISOSORBIDE

FDA Submissions

TYPE 2; Type 2 - New Active IngredientORIG1AP1974-01-30STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1975-08-25STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1978-06-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1980-01-09STANDARD
LABELING; LabelingSUPPL6AP1980-12-10
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1981-04-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1988-03-04STANDARD
LABELING; LabelingSUPPL9AP1993-07-13
LABELING; LabelingSUPPL11AP1998-05-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1999-04-07STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL8Null0
SUPPL12Null0

CDER Filings

ALCON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 17063
            [companyName] => ALCON
            [docInserts] => ["",""]
            [products] => [{"drugName":"ISMOTIC","activeIngredients":"ISOSORBIDE","strength":"100GM\/220ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ISMOTIC","submission":"ISOSORBIDE","actionType":"100GM\/220ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.